These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

505 related items for PubMed ID: 27050147

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Overexpression of ZFX confers self-renewal and chemoresistance properties in hepatocellular carcinoma.
    Lai KP, Chen J, He M, Ching AK, Lau C, Lai PB, To KF, Wong N.
    Int J Cancer; 2014 Oct 15; 135(8):1790-9. PubMed ID: 24585547
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. ψ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling.
    Ding J, Wen W, Xiang D, Yin P, Liu Y, Liu C, He G, Cheng Z, Yin J, Sheng C, Zhang W, Nan F, Ye W, Zhang X, Wang H.
    Oncotarget; 2015 May 10; 6(13):11627-39. PubMed ID: 25890498
    [Abstract] [Full Text] [Related]

  • 27. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
    Chen X, Wang Y, Tao J, Shi Y, Gai X, Huang F, Ma Q, Zhou Z, Chen H, Zhang H, Liu Z, Sun Q, Peng H, Chen R, Jing Y, Yang H, Mao Y, Zhang H.
    Gastroenterology; 2015 Sep 10; 149(3):741-52.e14. PubMed ID: 25980751
    [Abstract] [Full Text] [Related]

  • 28. Knock out CD44 in reprogrammed liver cancer cell C3A increases CSCs stemness and promotes differentiation.
    Han S, Guo J, Liu Y, Zhang Z, He Q, Li P, Zhang M, Sun H, Li R, Li Y, Zeng W, Liu J, Lian L, Gao Y, Shen L.
    Oncotarget; 2015 Dec 29; 6(42):44452-65. PubMed ID: 26540347
    [Abstract] [Full Text] [Related]

  • 29. C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway.
    Ching RHH, Sze KMF, Lau EYT, Chiu YT, Lee JMF, Ng IOL, Lee TKW.
    Oncotarget; 2017 Apr 04; 8(14):23507-23516. PubMed ID: 28186991
    [Abstract] [Full Text] [Related]

  • 30. CXCL14 inhibits the growth and promotes apoptosis of hepatocellular carcinoma cells via suppressing Akt/mTOR pathway.
    Bi J, Liu Q, Sun Y, Hu X, He X, Xu C.
    J Recept Signal Transduct Res; 2021 Dec 04; 41(6):593-603. PubMed ID: 33108937
    [Abstract] [Full Text] [Related]

  • 31. IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular Carcinoma.
    Cheng BY, Lau EY, Leung HW, Leung CO, Ho NP, Gurung S, Cheng LK, Lin CH, Lo RC, Ma S, Ng IO, Lee TK.
    Cancer Res; 2018 May 01; 78(9):2332-2342. PubMed ID: 29483095
    [Abstract] [Full Text] [Related]

  • 32. Increasing matrix stiffness upregulates vascular endothelial growth factor expression in hepatocellular carcinoma cells mediated by integrin β1.
    Dong Y, Xie X, Wang Z, Hu C, Zheng Q, Wang Y, Chen R, Xue T, Chen J, Gao D, Wu W, Ren Z, Cui J.
    Biochem Biophys Res Commun; 2014 Feb 14; 444(3):427-32. PubMed ID: 24472554
    [Abstract] [Full Text] [Related]

  • 33. The Natural Pigment Violacein Potentially Suppresses the Proliferation and Stemness of Hepatocellular Carcinoma Cells In Vitro.
    Kim YJ, Yuk N, Shin HJ, Jung HJ.
    Int J Mol Sci; 2021 Oct 03; 22(19):. PubMed ID: 34639072
    [Abstract] [Full Text] [Related]

  • 34. Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.
    Corominas-Faja B, Cufí S, Oliveras-Ferraros C, Cuyàs E, López-Bonet E, Lupu R, Alarcón T, Vellon L, Iglesias JM, Leis O, Martín ÁG, Vazquez-Martin A, Menendez JA.
    Cell Cycle; 2013 Sep 15; 12(18):3109-24. PubMed ID: 23974095
    [Abstract] [Full Text] [Related]

  • 35. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
    Toh TB, Lim JJ, Hooi L, Rashid MBMA, Chow EK.
    J Hepatol; 2020 Jan 15; 72(1):104-118. PubMed ID: 31541681
    [Abstract] [Full Text] [Related]

  • 36. The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma.
    Pivonello C, Negri M, De Martino MC, Napolitano M, de Angelis C, Provvisiero DP, Cuomo G, Auriemma RS, Simeoli C, Izzo F, Colao A, Hofland LJ, Pivonello R.
    Oncotarget; 2016 Mar 01; 7(9):9718-31. PubMed ID: 26756219
    [Abstract] [Full Text] [Related]

  • 37. Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma.
    Gao X, Sheng Y, Yang J, Wang C, Zhang R, Zhu Y, Zhang Z, Zhang K, Yan S, Sun H, Wei J, Wang X, Yu X, Zhang Y, Luo Q, Zheng Y, Qiao P, Zhao Y, Dong Q, Qin L.
    J Exp Clin Cancer Res; 2018 Jul 31; 37(1):179. PubMed ID: 30064482
    [Abstract] [Full Text] [Related]

  • 38. Overexpression of microRNA-133b is associated with the increased survival of patients with hepatocellular carcinoma after curative hepatectomy: Involvement of the EGFR/PI3K/Akt/mTOR signaling pathway.
    Wang X, Zeng J, Wang L, Zhang X, Liu Z, Zhang H, Dong J.
    Oncol Rep; 2017 Jul 31; 38(1):141-150. PubMed ID: 28586051
    [Abstract] [Full Text] [Related]

  • 39. Transcription factor 7 like 2 promotes metastasis in hepatocellular carcinoma via NEDD9-mediated activation of AKT/mTOR signaling pathway.
    Tang L, Xu S, Wei R, Fan G, Zhou J, Wei X, Xu X.
    Mol Med; 2024 Jul 25; 30(1):108. PubMed ID: 39060928
    [Abstract] [Full Text] [Related]

  • 40. Gefitinib resistance in HCC mahlavu cells: upregulation of CD133 expression, activation of IGF-1R signaling pathway, and enhancement of IGF-1R nuclear translocation.
    Bodzin AS, Wei Z, Hurtt R, Gu T, Doria C.
    J Cell Physiol; 2012 Jul 25; 227(7):2947-52. PubMed ID: 21959795
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.